- Home
- GAIA vs PLRX Comparison
GAIA vs PLRX Comparison
Compare GAIA & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAIA
- PLRX
- Stock Information
- Founded
- GAIA 1988
- PLRX 2015
- Country
- GAIA United States
- PLRX United States
- Employees
- GAIA N/A
- PLRX N/A
- Industry
- GAIA Movies/Entertainment
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- GAIA Consumer Discretionary
- PLRX Health Care
- Exchange
- GAIA Nasdaq
- PLRX Nasdaq
- Market Cap
- GAIA 104.1M
- PLRX 87.0M
- IPO Year
- GAIA 1999
- PLRX 2020
- Fundamental
- Price
- GAIA $4.45
- PLRX $1.54
- Analyst Decision
- GAIA Strong Buy
- PLRX Hold
- Analyst Count
- GAIA 2
- PLRX 10
- Target Price
- GAIA $8.00
- PLRX $9.79
- AVG Volume (30 Days)
- GAIA 43.9K
- PLRX 1.2M
- Earning Date
- GAIA 05-05-2025
- PLRX 05-05-2025
- Dividend Yield
- GAIA N/A
- PLRX N/A
- EPS Growth
- GAIA N/A
- PLRX N/A
- EPS
- GAIA N/A
- PLRX N/A
- Revenue
- GAIA $90,363,000.00
- PLRX N/A
- Revenue This Year
- GAIA $14.66
- PLRX N/A
- Revenue Next Year
- GAIA $16.14
- PLRX N/A
- P/E Ratio
- GAIA N/A
- PLRX N/A
- Revenue Growth
- GAIA 12.36
- PLRX N/A
- 52 Week Low
- GAIA $2.93
- PLRX $1.10
- 52 Week High
- GAIA $6.53
- PLRX $16.52
- Technical
- Relative Strength Index (RSI)
- GAIA 64.02
- PLRX 41.16
- Support Level
- GAIA $3.68
- PLRX $1.10
- Resistance Level
- GAIA $4.13
- PLRX $1.59
- Average True Range (ATR)
- GAIA 0.35
- PLRX 0.11
- MACD
- GAIA 0.12
- PLRX 0.14
- Stochastic Oscillator
- GAIA 96.82
- PLRX 89.80
About GAIA Gaia Inc.
Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.